Abstract
Human influenza viruses attach to sialic acid with an α2,6linkage (SAα2,6Gal) on the airway epithelial cells, and the entry of the viruses into the cells and uncoating of the viruses require low pH of endosomes. Bafilomycin A1, a macrolide antibiotic and a specific inhibitor of vacuolar H+-ATPase, inhibits growth of type A and type B human influenza viruses in Madin-Darby canine kidney cells. However, the inhibitory effects of clinically used macrolide antibiotics on influenza virus infection in human airways have not been studied. To examine the effects of clarithromycin on seasonal human influenza virus infection, cultured human tracheal epithelial cells were infected with type A influenza virus (H3N2). Influenza virus infection increased viral titers and the content of cytokines, including interleukin (IL)-1β and IL-6, in supernatant fluids, and viral RNA in the cells. Clarithromycin reduced viral titers and the content of cytokines in supernatant fluids, viral RNA in the cells, and the susceptibility to virus infection. Clarithromycin reduced the expression of SAα2,6Gal, a receptor for human influenza virus, on the mucosal surface of human tracheae, and the number and fluorescence intensity of acidic endosomes in the cells from which viral ribonucleoproteins enter into the cytoplasm. Furthermore, clarithromycin reduced nuclear factor-κB (NF-κB) proteins, including p50 and p65, in the nuclear extracts. These results suggest that clarithromycin may inhibit seasonal human influenza virus infection by reducing SAα2,6Gal partly through the inhibition of NF-κB, and increasing pH in endosomes in airway epithelial cells. Clarithromycin may modulate airway inflammation in influenza virus infection.
Footnotes
- Received October 3, 2009.
- Accepted December 28, 2009.
This study was funded in part by Health, Labor Welfare Sciences Research Grants for Research on Measures for Intractable Diseases [Grant H20 nanchi ippan 035] from the Japanese Government; Abbott Japan Co. Ltd.; and Taisho Toyama Pharmaceutical Co. Ltd.
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
doi:10.1124/jpet.109.162149.
-
ABBREVIATIONS:
- COPD
- chronic obstructive pulmonary disease
- SAα2,6Gal
- sialic acid with an α2,6linkage
- RNP
- ribonucleoprotein
- MDCK
- Madin-Darby canine kidney
- IL
- interleukin
- FluA
- type A seasonal human influenza
- USG
- Ultroser G
- PBS
- phosphate-buffered saline
- MEM
- minimal essential medium
- DF-12
- DMEM-Ham's F-12 medium
- TCID
- tissue culture infective dose
- CPE
- cytopathic effects
- RT-PCR
- reverse transcription-polymerase chain reaction
- FITC
- fluorescein isothiocyanate
- NF-κB
- nuclear factor κB
- LDH
- lactate dehydrogenase.
- Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|